Related Experiment Video
Updated: Jun 20, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Endocannabinoids can open the pain gate
MacDonald J Christie1, Christophe Mallet
1Brain and Mind Research Institute, University of Sydney, New South Wales, Australia. mac.c@usyd.edu.au
Abstract:
Endocannabinoids produced in the spinal cord can enhance pain by dampening the synapses of inhibitory interneurons that usually prevent the perception of innocuous stimuli as painful. This mechanism promotes pain responsiveness to normally innocuous mechanical stimuli in the skin surrounding a site of injury in both animals and humans subjected to sustained stimulation of pain-sensing nerves. The pain-promoting action of endocannabinoids wanes during the development of chronic pain that is induced by inflammation or nerve injury. This finding may partially explain why, in human trials, cannabinoid drugs have been negative for treatment of most types of acute and postsurgical pain but are effective for some chronic pain states.
Related Concept Videos
Pain
Analgesia and Pain Management
Nociception
Opioid Receptors: Overview
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
